# C_2011023EN.01000801.xml

| 25.1.2011 | EN | Official Journal of the European Union | C 23/8 |
| --- | --- | --- | --- |

25.1.2011

EN

Official Journal of the European Union

C 23/8

---

Prior notification of a concentration

(Case COMP/M.6050 — DuPont/DSM/Actamax JV)

(Text with EEA relevance)

2011/C 23/06

| 1. | On 17 January 2011, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which the undertakings DSM PTG, Inc., belonging to the group Royal DSM NV (‘DSM’, The Netherlands) and E.I. du Pont de Nemours and Company (‘DuPont’, USA) acquire within the meaning of Article 3(1)(b) of the Merger Regulation joint control of the undertaking Actamax Surgical Materials LLC (‘Actamax’, USA) by way of purchase of shares in a newly created company constituting a joint venture. |
| --- | --- |

1.

On 17 January 2011, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which the undertakings DSM PTG, Inc., belonging to the group Royal DSM NV (‘DSM’, The Netherlands) and E.I. du Pont de Nemours and Company (‘DuPont’, USA) acquire within the meaning of Article 3(1)(b) of the Merger Regulation joint control of the undertaking Actamax Surgical Materials LLC (‘Actamax’, USA) by way of purchase of shares in a newly created company constituting a joint venture.

1

| 2. | The business activities of the undertakings concerned are:






  — | DSM is engaged in the research, development, production, distribution, and sale of a variety of nutritional and pharmaceutical products, performance materials, polymer intermediates, and base chemicals and materials, |
| --- | --- | --- |

2.

The business activities of the undertakings concerned are:

—

DSM is engaged in the research, development, production, distribution, and sale of a variety of nutritional and pharmaceutical products, performance materials, polymer intermediates, and base chemicals and materials,

| — | DuPont is a multinational diversified company engaged in the research, development, production, distribution, and sale of a variety of chemical products, plastics, agro-chemicals, paints, seed, and other materials, |
| --- | --- |

—

DuPont is a multinational diversified company engaged in the research, development, production, distribution, and sale of a variety of chemical products, plastics, agro-chemicals, paints, seed, and other materials,

| — | Actamax will develop and commercialise advanced biocompatible surgical materials (notably adhesion barriers, tissue adhesives, and hemostatic and ophthalmic sealants). |
| --- | --- |

—

Actamax will develop and commercialise advanced biocompatible surgical materials (notably adhesion barriers, tissue adhesives, and hemostatic and ophthalmic sealants).

| 3. | On preliminary examination, the Commission finds that the notified transaction could fall within the scope the EC Merger Regulation. However, the final decision on this point is reserved. |
| --- | --- |

3.

On preliminary examination, the Commission finds that the notified transaction could fall within the scope the EC Merger Regulation. However, the final decision on this point is reserved.

| 4. | The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.
  Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (+32 22964301), by e-mail to COMP-MERGER-REGISTRY@ec.europa.eu or by post, under reference number COMP/M.6050 — DuPont/DSM/Actamax JV, to the following address:





  European Commission |
| --- | --- |
| Directorate-General for Competition |
| Merger Registry |
| J-70 |
| 1049 Bruxelles/Brussel |
| BELGIQUE/BELGIË |

4.

The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (+32 22964301), by e-mail to COMP-MERGER-REGISTRY@ec.europa.eu or by post, under reference number COMP/M.6050 — DuPont/DSM/Actamax JV, to the following address:

European Commission

Directorate-General for Competition

Merger Registry

J-70

1049 Bruxelles/Brussel

BELGIQUE/BELGIË

---

(1)  OJ L 24, 29.1.2004, p. 1 (the ‘EC Merger Regulation’).

1

---